Impact Naturals' Cannabidiol (CBD) Products Demonstrate Strong Safety Data in Landmark Study
Results from a comprehensive, 1000+ participant safety study sponsored by seventeen leading CBD companies, including category innovator Impact Naturals, confirm prior research that orally ingested cannabidiol (CBD) has a strong safety profile. Outcomes of the study include:
The trial provides data that addresses and will help to minimize the FDA's safety concerns regarding CBD. These results will be shared with the FDA on May 20, 2022.